Symmetry Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,930
| Closed | -$905K | – | 496 |
|
|
2024
Q2 | $905K | Sell |
1,930
-943
| -33% | -$442K | 0.05% | 176 |
|
|
2024
Q1 | $1.2M | Hold |
2,873
| – | – | 0.09% | 147 |
|
|
2023
Q4 | $1.18M | Hold |
2,873
| – | – | 0.06% | 148 |
|
|
2023
Q3 | $999K | Sell |
2,873
-208
| -7% | -$72.3K | 0.05% | 180 |
|
|
2023
Q2 | $1.08M | Hold |
3,081
| – | – | 0.06% | 183 |
|
|
2023
Q1 | $971K | Buy |
3,081
+943
| +44% | +$297K | 0.05% | 191 |
|
|
2022
Q4 | $617K | Hold |
2,138
| – | – | 0.04% | 277 |
|
|
2022
Q3 | $619K | Buy |
2,138
+358
| +20% | +$104K | 0.04% | 254 |
|
|
2022
Q2 | $502K | Buy |
+1,780
| New | +$502K | 0.03% | 317 |
|
|
2021
Q4 | – | Sell |
-1,233
| Closed | -$218K | – | 651 |
|
|
2021
Q3 | $218K | Hold |
1,233
| – | – | 0.01% | 618 |
|
|
2021
Q2 | $249K | Buy |
+1,233
| New | +$249K | 0.02% | 609 |
|
|
2021
Q1 | – | Sell |
-1,877
| Closed | -$444K | – | 648 |
|
|
2020
Q4 | $444K | Sell |
1,877
-79
| -4% | -$18.7K | 0.03% | 406 |
|
|
2020
Q3 | $532K | Sell |
1,956
-91
| -4% | -$24.8K | 0.05% | 301 |
|
|
2020
Q2 | $594K | Buy |
+2,047
| New | +$594K | 0.07% | 121 |
|